A strategic buyer purchases companies to advance an existing corporate strategy—not to resell in a typical fund timeline.

How it works

Strategics evaluate targets against product gaps, customer overlap, and competitive threats. They may pay more when combined margins improve or when losing the asset to a rival hurts. Antitrust review can slow or kill deals that PE might clear faster. Integration teams decide whether to keep the brand, fold the product, or shut duplicative R&D.

In venture exits, running a process with both strategics and sponsors usually improves outcomes.

Why it matters

• Founders: Ask what happens to your team and roadmap post-close; cultural fit matters as much as headline price.
• Investors: Strategics sometimes use stock as currency, shifting risk to your holders if the buyer’s shares fall.

Common mistake

Equating strategic interest with a sure close. Corporates drop deals late in diligence when synergy cases fail internal review.

Related ideas

Strategic acquisition, financial buyer, synergies, and competitive process.

When you will see it

Running a sale process with both strategics and financial sponsors usually improves price discovery and surfaces different risk views on the business.

Questions to ask

• Does this buyer compete with other customers on your cap table?
• What regulatory approvals could delay or block the deal?
• Is the buyer’s stock a currency you are willing to hold?

Practical takeaway

Treat strategic buyer as something to define precisely in writing—not assume everyone in the room shares the same meaning. In term sheets, board decks, and LP updates, tie the concept to a concrete decision: a vote, a price input, a fund policy, or a metric formula. When definitions drift, teams misprice risk, miss leverage, or waste cycles on the wrong conversation.